FILANA THERAPEUTICS INC (SAVA): Hedge Fund Ownership & Smart Money Signals (Q4 2025)

FILANA THERAPEUTICS INC (SAVA)

115 + Investors. Track Smart Money conviction in SAVA. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — SAVA

Based on 107 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q

For 2 consecutive quarters, more hedge funds added SAVA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🔻

Below peak — only 66% of 3.0Y high

66% of all-time peak

Only 107 funds hold SAVA today versus a peak of 163 funds at 2024 Q3 — just 66% of the maximum. Low institutional ownership can mean the stock is out of favor, but it also means there's a large pool of potential buyers if sentiment turns.

📉

Outflows — 26% fewer funds vs a year ago

fund count last 6Q

37 fewer hedge funds hold SAVA compared to a year ago (-26% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.

🟡

Slight buying edge — 51% buying

50 buying48 selling

Last quarter: 50 funds bought or added vs 48 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

➡️

Steady new buyers — ~22 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 16 → 19 → 20 → 22. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

🔒

56% of holders stayed for 2+ years

■ 56% conviction (2yr+) ■ 28% medium ■ 16% new

60 out of 107 hedge funds have held SAVA for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

💎

Buying through price weakness — shares +1%, value -32%

Value

-31%

+0%

Last quarter: funds added +1% more shares while total portfolio value only changed -32%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

📈

Growing discovery — still being found

37 → 16 → 19 → 20 → 22 new funds/Q

New funds entering each quarter: 16 → 19 → 20 → 22. A growing number of institutions are discovering SAVA each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.

🏛️

Deep conviction — 70% of holders stayed 2+ years

■ 70% veterans ■ 11% 1-2yr ■ 18% new

Of 115 current holders: 81 (70%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.

✅

Strong quality — 26% AUM from major funds

26% from top-100 AUM funds

24 of 107 holders rank in the top 100 by AUM, accounting for 26% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

1.7

out of 10

Low Exit Risk

Exit risk score 1.7/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2025 Q4)	Prior (2025 Q3)	Change
Funds Holding	115	112	2.68%
13F Shares	15M	15M	0.65%
Total Value	$30M	$44M	-31.63%
New Positions	22	20	+2
Increased Positions	43	38	+5
Closed Positions	16	20	-4
Reduced Positions	45	52	-7
Total Calls	6	7	-14.29%
Total Puts	6	6	-
PUT/CALL Ratio	1.0	0.86	Neutral

Metric

All 13F Filers (2025 Q4)

Prior (2025 Q3)

Change

Funds Holding

115

112

2.68%

13F Shares

15M

0.65%

Total Value

$30M

$44M

-31.63%

New Positions

Increased Positions

Closed Positions

-4

Reduced Positions

-7

Total Calls

-14.29%

Total Puts

PUT/CALL Ratio

1.0

0.86

Neutral

Institutional Holders (2026 Q1)

115 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in SAVA. Verified SEC 13F-HR filings.

FILTER:All New Added To Reduced No Change | Overweight >5% | SHOW: Active managers + show index funds

Top 15 institutional holders of SAVA — 2025 Q4 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	MAYPORT, LLC	0.00%	13,400	$23K
2	Activest Wealth Management	0.00%	4,001	$7K
3	Apollon Wealth Management, LLC	0.00%	35,053	$59K
4	AlphaQuest LLC	0.00%	5,026	$10K
5	SBI Securities Co., Ltd.	0.00%	1,231	$2K
6	SALEM INVESTMENT COUNSELORS INC	0.00%	275	—
7	HSBC HOLDINGS PLC	0.00%	10,000	$17K
8	Golden State Wealth Management, LLC	0.00%	36	—
9	MATHER GROUP, LLC.	0.00%	250	—
10	CREATIVE FINANCIAL DESIGNS INC /ADV	0.00%	40	—
11	NISA INVESTMENT ADVISORS, LLC	0.00%	362	—
12	LRI Investments, LLC	0.00%	10	—
13	HM PAYSON & CO	0.00%	50	—
14	IFP Advisors, Inc	0.00%	10	—
15	Farther Finance Advisors, LLC	0.00%	16	—

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — FILANA THERAPEUTICS INC (SAVA)

What does the Smart Money Trend signal show for SAVA?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added SAVA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for SAVA?

Slight buying edge — 51% buying: Last quarter: 50 funds bought or added vs 48 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for SAVA holders?

Strong quality — 26% AUM from major funds: 24 of 107 holders rank in the top 100 by AUM, accounting for 26% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held SAVA?

56% of holders stayed for 2+ years: 60 out of 107 hedge funds have held SAVA for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

FILANA THERAPEUTICS INC (SAVA)

Smart Money Signals — SAVA

Buying streak — 2 quarters in a row

Below peak — only 66% of 3.0Y high

Outflows — 26% fewer funds vs a year ago

Slight buying edge — 51% buying

Steady new buyers — ~22 new funds per quarter

56% of holders stayed for 2+ years

Buying through price weakness — shares +1%, value -32%

Growing discovery — still being found

Deep conviction — 70% of holders stayed 2+ years

Strong quality — 26% AUM from major funds

Hedge Fund Ownership: SAVA

Market Analysis: SAVA

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: SAVA

Hedge Fund Positioning: SAVA

Statistics: SAVA

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q1)

Frequently Asked Questions — FILANA THERAPEUTICS INC (SAVA)

Welcome to 13Foresight!